http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H05194212-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8ffdd0403966b3257cdff37810d77910
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
filingDate 1992-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02901ae366416eb3684b55bc88f8136b
publicationDate 1993-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H05194212-A
titleOfInvention Ocular inflammation treatment method
abstract (57) [Summary] [Structure] A method for treating ocular inflammation in a mammal comprising administering an anti-inflammatory effective amount of rapamycin, a composition for treating ocular inflammation, and use of rapamycin for the treatment of ocular inflammation. [Effect] By administering an anti-inflammatory effective amount of rapamycin to a mammal having ocular inflammation, the ocular inflammation can be effectively treated without the harmful side effects of corticosteroid, cyclosporin A and the like.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021132565-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009530406-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002522485-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-970032856-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002520355-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007505906-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220122612-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8618088-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9452156-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006511475-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8690942-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9737650-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011001380-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011088934-A
priorityDate 1991-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1912
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1912
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395632
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284616
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551199
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11057
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408128213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4737
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535600
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454707268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452529979
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5917
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2909
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61363
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536128

Total number of triples: 52.